Literature DB >> 3592424

"Cost containment" in the management of hypertension.

M Moser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3592424     DOI： 10.7326/0003-4819-107-1-107

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  10 in total

Review 1.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

2.  Guidelines for medical practice: 1. The reasons why.

Authors:  A L Linton; D K Peachey
Journal:  CMAJ       Date:  1990-09-15       Impact factor: 8.262

Review 3.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

Review 4.  What do you do when the blood pressure is up? An approach to the known hypertensive who has an elevated blood pressure.

Authors:  R L Schiff; M H Cohen; A Balson
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

5.  Hypertension in the elderly: what price therapy?

Authors:  M Gordon
Journal:  Can Fam Physician       Date:  1989-12       Impact factor: 3.275

6.  Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system.

Authors:  J N Aucott; E Pelecanos; R Dombrowski; S M Fuehrer; J Laich; D C Aron
Journal:  J Gen Intern Med       Date:  1996-03       Impact factor: 5.128

Review 7.  Economics of hypertension control. World Hypertension League.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 8.  Pharmacoeconomic burden of undertreating hypertension.

Authors:  Luca Degli Esposti; Giorgia Valpiani
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Do resident and staff physicians differ in the types and costs of antihypertensive drugs they select?

Authors:  T H Payne; J D Goodson; M M Morgan; G O Barnett
Journal:  J Gen Intern Med       Date:  1991 Sep-Oct       Impact factor: 5.128

10.  Economic aspects of hypertension treatment in Poland.

Authors:  Jana Krzysztoszek; Dorota Koligat; Piotr Ratajczak; Wiesław Bryl; Maciej Cymerys; Karolina Hoffmann; Ewelina Wierzejska; Paweł Kleka
Journal:  Arch Med Sci       Date:  2013-01-21       Impact factor: 3.318
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.